Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $143.35M.
ENTERPRISE VALUE (EV)
$143.35M
Korsana Biosciences, Inc.
Market Cap
$146.59M
Enterprise Value (EV)
$143.35M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | $146.59M | $143.35M |
| Immuneering Corporation (IMRX)vs › | $145.75M | $108.06M |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | $86.34M |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | $128.84M |
| Nyxoah S.A. (NYXH)vs › | $143.10M | $129.92M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.96M | $123.08M |
| Codexis, Inc. (CDXS)vs › | $151.93M | $197.35M |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.63M | $34.30M |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | $191.68M |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | $7.94M |
Market Cap
$146.59M
Total Debt
$0.00
Cash
$3.24M
Enterprise Value
$143.35M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
